Vor Biopharma Inc. Common Stock

VORNASDAQ • USD
18.24 USD
↘ 0.73 (3.86%)🟢LIVE (AS OF 10:59 AM EST)
🟢Market: OPEN

Shares of Vor Biopharma Inc. Common Stock (VOR) are trading at $18.24. The stock presents a bearish profile across the board: technical indicators signal "Sell" and our fundamental models agree with a "Sell" rating. This is driven by a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bullish Golden Cross on the moving averages. Valuation metrics suggest VOR is trading at a discount to its peers, earning an "Attractively Valued" rating.

Technical & fundamental data as of Nov 16, 2026.

Open?$18.96
High?$19.70
Low?$17.75
Prev. Close?$18.97
Volume?200.5K
Avg. Volume?761.1K
VWAP?$18.20
Rel. Volume?0.26x
Bid / Ask
Bid?$17.21 × 100
Ask?$18.07 × 100
Spread?$0.86
Midpoint?$17.64
Valuation & Ratios
Market Cap?1.2B
Shares Out?61.4M
Float?42.2M
Float %?71.4%
P/E Ratio?0.86
P/B Ratio?-8.50
EPS?$22.04
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Vor Biopharma Inc is a clinical-stage biopharmaceutical company focused on developing novel therapies for the treatment of autoimmune diseases. Its program, telitacicept, is a potential first- and best-in-class dual BAFF/APRIL inhibitor designed to suppress the signaling pathways that drive the maturation, proliferation, and survival of harmful B cells, including self-reactive B cells, thereby reducing autoantibody production and preventing downstream tissue damage.
Employees
76
Market Cap
1.2B
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Listed
2021-02-05
Address
500 BOYLSTON STREET
BOSTON, MA 02116
Phone: 617-655-6580
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-1/3)
Medium-Term (Wave)?▼ Bearish(-1/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
0
Momentum?
50
Short Sent.?
45
Piotroski F-Score?0/9Weak
Altman Z-Score?-3.27Distress
Confidence?59%Low
Full Fundamental Analysis →
Short InterestHigh
Short % of Float?17.77%High
Short Interest?7.5M
Days to Cover?9.9
Free Float42.2M
Avg Daily Volume759.5K
Settlement Date2026-10-30
Financial Health
Current Ratio?13.50Strong
Quick Ratio?13.50Strong
Cash Ratio?2.17Strong
Debt/Equity?-0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
100/100
P/E?
Peers
100
S&P
97
0.9CHEAP▾
P/B?
S&P
97
-8.50CHEAP▾
P/S?
N/A▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-6.1CHEAP▾
EV/Sales?
N/A▾
Returns & Efficiency
ROE?
S&P
3
-986.9%WEAK▾
ROA?
Peers
50
S&P
97
272.8%STRONG▾
Cash Flow & Enterprise
FCF?$-119678000
Enterprise Value?$1.1B
Fundamentals ratios updated end of day